Oral Pharmacological Treatment for Knee Osteoarthritis

Managing knee osteoarthritis requires selecting the right pharmacological strategy for each patient. This protocol covers a specific oral medication approach guided by structured, evidence-based clinical criteria.

Treatment approach This protocol specifies an oral systemic agent. The complete regimen — including the specific medication, clinical selection considerations, and guidance on use — is available in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Though duloxetine is approved for OA in some countries, there were only conditional or weak recommendations for its use across all guidelines, reflecting general concerns about efficacy and tolerability.

DOI: 10.1016/j.rdc.2022.03.009.

View source ↗